Want to see AMIX full AI Analyst Report?
AMIX Stock Chart & Stats
$0.39
-$0.14(-4.75%)
At close: 4:00 PM EST
$0.39
-$0.14(-4.75%)
Day’s Range― - ―
52-Week Range$4.21 - $55.42
Previous CloseN/A
Volume72.00K
Average Volume (3M)456.51K
Market Cap
$2.67M
Enterprise Value-$5.00M
Total Cash (Recent Filing)$7.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding543,302
10 Day Avg. Volume742,337
30 Day Avg. Volume456,513
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.48
Price to Sales (P/S)0.00
P/FCF Ratio-0.23
Enterprise Value/Market Cap-1.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.67K
Enterprise Value/Ebitda0.30
Forecast
1Y Price Target
$2.00Price Target Upside412.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Patent GrantThe new patent strengthens Autonomix's intellectual property portfolio, enhancing its competitive edge in medical device innovation and potentially expanding its market reach.
Positive Trial OutcomesSuccessful trial results could lead to expanded applications and market opportunities, improving long-term growth prospects by addressing unmet medical needs.
Warrant ExerciseThe warrant exercise provides additional capital, bolstering financial stability and supporting ongoing R&D efforts, which is crucial for future growth and innovation.
Bears Say
Zero RevenueLack of revenue generation is a critical concern, indicating challenges in monetizing products and achieving sustainable growth, which could impact long-term viability.
Negative Cash FlowNegative cash flow highlights operational inefficiencies and reliance on external financing, posing risks to financial health and limiting strategic flexibility.
Reliance On FinancingDependence on external financing can lead to vulnerability if funding becomes scarce, affecting the company's ability to sustain operations and invest in growth initiatives.
Autonomix Medical, Inc. News
AMIX FAQ
What was Autonomix Medical, Inc.’s price range in the past 12 months?
Autonomix Medical, Inc. lowest stock price was $4.21 and its highest was $55.42 in the past 12 months.
What is Autonomix Medical, Inc.’s market cap?
Autonomix Medical, Inc.’s market cap is $2.67M.
When is Autonomix Medical, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Autonomix Medical, Inc.’s earnings last quarter?
Currently, no data Available
Is Autonomix Medical, Inc. overvalued?
According to Wall Street analysts Autonomix Medical, Inc.’s price is currently Undervalued.
Does Autonomix Medical, Inc. pay dividends?
Autonomix Medical, Inc. does not currently pay dividends.
What is Autonomix Medical, Inc.’s EPS estimate?
Autonomix Medical, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Autonomix Medical, Inc. have?
Autonomix Medical, Inc. has 543,302 shares outstanding.
What happened to Autonomix Medical, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Autonomix Medical, Inc.?
Currently, no hedge funds are holding shares in AMIX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
AMIX Stock 12 Month Forecast
Average Price Target
$2.00
▲(412.82% Upside)
Technical Analysis
Ownership Overview
―
Insiders
6.80% Mutual Funds
0.07% Other Institutional Investors
93.14% Public Companies and
Individual Investors